-
ALC-0159: An Experimental Design Guide
2026-09-30
ALC-0159 is a PEG-conjugated lipid excipient used to study mRNA lipid nanoparticle performance. This guide connects formulation variables with oncology-relevant assays while separating delivery effects from the broader biology of mRNA vaccination and immune checkpoint inhibition.
-
Sunitinib RTK Workflows for Cancer Models
2026-09-30
Build reproducible Sunitinib assays around RTK signaling, angiogenesis, apoptosis, and genotype-aware drug sensitivity. This workflow connects renal cell carcinoma and nasopharyngeal carcinoma models with the ATRX-deficient glioma findings that can guide combination studies and response stratification.
-
AM 281: CB1 Antagonist Workflow for TBI Research
2026-09-29
AM 281 enables mechanism-focused interrogation of CB1 signaling in traumatic brain injury, glutamate excitotoxicity, and memory impairment research. This workflow connects receptor pharmacology with GLT-1, CREB, neuronal apoptosis, and behavioral endpoints while emphasizing formulation control and assay-specific troubleshooting.
-
MG-132 (Z-LLL-al) Experimental Workflow Guide
2026-09-29
MG-132 (Z-LLL-al) gives researchers a controllable way to connect proteasome blockade with apoptosis, cell-cycle changes, and oxidative stress. This workflow emphasizes dose timing, orthogonal readouts, and careful interpretation when translating proteostasis findings into cancer or antiviral research.
-
Sinapine Targets PLCβ3 EF Hands in Cardiovascular Disease
2026-09-28
The April 2024 Phytomedicine study identifies sinapine as a chemical probe that targets the PLCβ3 EF-hand region, including Asn-260, to disrupt Gαq–PLCβ3 association and reduce aldosteronism and hypertension in animal models. Its main significance is a more pathway-focused alternative to broad Gαq or pan-PLC inhibition, although the evidence remains preclinical and requires wider validation.
-
Verapamil in Urothelial Hypoxia Research
2026-09-28
A duration-resolved urothelial hypoxia model separates an early hypoxic response from later caspase-1-associated inflammation. Learn how to use Verapamil as a cautious pathway probe, structure matched controls, and troubleshoot interpretation without treating it as a selective TXNIP reagent.
-
PROTACs Target Botulinum Neurotoxin Light Chains
2026-09-27
Tsai and colleagues report proof of principle for using PROTAC-based strategies to direct botulinum neurotoxin catalytic light chains toward proteasomal degradation. The work points to a way to tune toxin persistence, while highlighting that therapeutic clearance and clinical benefit remain questions for further study.
-
MMAE and Tumor Plasticity: A Translational Framework
2026-09-26
Monomethyl auristatin E (MMAE) offers a potent antimitotic payload for antibody-drug conjugate research, while findings on EBV-driven plasticity in nasopharyngeal carcinoma point to a distinct differentiation-based strategy. This article connects the biology without overstating the evidence—and offers practical guidance for testing each approach.
-
Acetoacetic Acid Sodium Salt in Translational Research
2026-09-25
A translational framework for using acetoacetic acid sodium salt to investigate ketone-body biology, diabetes-related metabolic imbalance, and the limits of moving from controlled experiments to clinical interpretation.
-
Smoothened and Olfactory Function in Honeybees
2026-09-25
Guo et al. characterize Smoothened (Smo) in Apis mellifera and use pharmacological modulation to connect Smo expression with olfactory receptor transcripts, antennal responses, and odor-choice behavior. The results support a role for Smo in honeybee olfaction, while leaving open whether the observed effects are direct and how broadly they transfer across species.
-
MG-132 and the Redox Logic of Cancer Cell Death
2026-09-24
MG-132 offers a way to perturb proteasome function and study apoptosis, cell-cycle control, and oxidative stress. This article connects that experimental toolkit to emerging evidence on ACSL1-mediated ferroptosis resistance in ovarian cancer—while distinguishing established findings from the questions researchers still need to test.
-
KG-501 in Macrophage Transcription Assays
2026-09-24
KG-501 offers a practical way to test whether CREB–coactivator signaling contributes to transcriptional changes in macrophages and cancer-cell models. Here, a colitis-associated colorectal cancer study provides a disease-relevant example, while a stepwise workflow explains how to use the compound without mistaking it for a direct TLR4 inhibitor.
-
Methotrexate: Folate Biology and Assay Interpretation
2026-09-23
Methotrexate is a folate antagonist whose effects on proliferation, activated T cells, and inflammation depend on cellular context. This guide connects its pharmacology to folate-linked methylation biology and shows how to distinguish target engagement from downstream assay phenotypes.
-
Dihydrotestosterone as a Translational Lever
2026-09-23
Dihydrotestosterone is more than an androgen receptor agonist: it is a mechanistic probe for connecting receptor activation with EGFR, ERBB2, AKT, ERK, and muscle-response phenotypes. This article outlines how translational researchers can use DHT with stronger causal controls, interpret cross-domain evidence responsibly, and design assays that move beyond a conventional product-page perspective.
-
Deep Learning for Sweetpotato Virus Disease Imaging
2026-09-22
Ding et al. developed an attention-enhanced DeepLabV3+ semantic segmentation model for identifying sweetpotato virus disease lesions in field photographs. The approach achieved strong performance on its primary dataset but showed a substantial reduction on an independent validation set, highlighting both the promise of field-based plant disease imaging and the importance of external generalization testing.